CytoMed Therapeutics Ltd. held its annual shareholders meeting on June 26, 2025. The meeting included several proposals, all of which were approved. The proposals included the adoption of the Directors' Statement and the audited financial statements for the financial year ended December 31, 2024. Additionally, the re-election of Dr. ZENG Jieming as Director was approved, and a special resolution to alter the Constitution to remove the requirement to publish notice of general meetings in the daily press was also passed.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytomed Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-017696), on July 03, 2025, and is solely responsible for the information contained therein.